DrugPatentWatch Database Preview
Keryx Biopharms Company Profile
» See Plans and Pricing
What is the competitive landscape for KERYX BIOPHARMS, and what generic alternatives to KERYX BIOPHARMS drugs are available?
KERYX BIOPHARMS has one approved drug.
There are fifteen US patents protecting KERYX BIOPHARMS drugs.
There are one hundred and twenty-five patent family members on KERYX BIOPHARMS drugs in twenty-six countries.
Summary for Keryx Biopharms
| International Patents: | 125 |
| US Patents: | 15 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Keryx Biopharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | 8,609,896 | Start Trial | Y | Start Trial | |||
| Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | 8,901,349 | Start Trial | Start Trial | ||||
| Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | 8,754,258 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Keryx Biopharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2014240405 | Start Trial |
| Canada | 2272711 | Start Trial |
| Japan | 2013231057 | Start Trial |
| Eurasian Patent Organization | 018245 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
